MedTrace Logo

Telemonitoring Program in the Vulnerable Phase After Hospitalization for Heart Failure

NCT05972746 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2023-08-02

No results posted yet for this study

Summary

This pragmatic clinical trial aims to evaluate the impact of a telemonitoring program with an electronic alert system compared to standard treatment on the perception of self-care in patients after hospitalization for decompensated HF at 3 months post-discharge. And secondarily to evaluate its impact on clinical events, NT-proBNP and efficacy and safety to facilitate the use and titration of the recommended drugs in patients with reduced ejection fraction at 90 days.

Conditions

Interventions

DEVICE

Telemonitoring with electronic alerts

Patients assigned to this group will receive standard care plus a telemonitoring program.

OTHER

Standard of care

Standard of care

Sponsors & Collaborators

  • Instituto Cardiovascular de Buenos Aires

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-07
Primary Completion
2023-10-07
Completion
2023-11-07

Countries

  • Argentina

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05972746 on ClinicalTrials.gov